BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10185365)

  • 1. FAHS refers Stark II reactions to HCFA.
    Gogal L
    Hosp Outlook; 1998 May; 1(5):4. PubMed ID: 10185365
    [No Abstract]   [Full Text] [Related]  

  • 2. HCFA issues. Stark II proposed rules.
    Portman RM; Lisa GC
    Bull Am Coll Surg; 1998 Jun; 83(6):20-23. PubMed ID: 10180259
    [No Abstract]   [Full Text] [Related]  

  • 3. Proposed Stark II regulations unveiled. HCFA interpretation of self-referral rules recognize circumstances of dialysis providers.
    Riley JB; Pristave RJ
    Nephrol News Issues; 1998 Jun; 12(6):13-5. PubMed ID: 9697471
    [No Abstract]   [Full Text] [Related]  

  • 4. Stark reality. How Stark I and II will impact physician relationships.
    Avery PA; Wachler AB
    Mich Health Hosp; 1995; 31(5):34-6. PubMed ID: 10151703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New final Stark II regulations.
    Pontius CA
    MLO Med Lab Obs; 2001 May; 33(5):14. PubMed ID: 11373811
    [No Abstract]   [Full Text] [Related]  

  • 6. Specialty hospitals: Congress should act to level the playing field.
    Grassley C
    Hosp Outlook; 2005; 8(2):13. PubMed ID: 16075770
    [No Abstract]   [Full Text] [Related]  

  • 7. The stark reality for physician-owned specialty hospitals.
    Oostdyk S; McCormick D
    Health Care Law Mon; 2011 Nov; 2011(11):2-11. PubMed ID: 22117495
    [No Abstract]   [Full Text] [Related]  

  • 8. Finally, HCFA proposes regulations interpreting stark II.
    Katayama AC
    WMJ; 1998 Mar; 97(3):67-73. PubMed ID: 9540454
    [No Abstract]   [Full Text] [Related]  

  • 9. Deciphering Stark II may test your patience.
    Hosp Peer Rev; 1998 Aug; 23(8):148-9. PubMed ID: 10181313
    [No Abstract]   [Full Text] [Related]  

  • 10. A review of the new Stark Phase II regulations.
    Siegel S
    Health Care Law Mon; 2004 Jun; ():3-15. PubMed ID: 15250190
    [No Abstract]   [Full Text] [Related]  

  • 11. How the new Stark II regulations affect group practices.
    Larios D; Meyer A
    Tenn Med; 1998 Apr; 91(4):128-30. PubMed ID: 9564245
    [No Abstract]   [Full Text] [Related]  

  • 12. Stark II Final Rule (Phase I): some answers, more questions.
    Shay AW; Murphy SL
    Manag Care Q; 2002; 10(1):38-46. PubMed ID: 15988954
    [No Abstract]   [Full Text] [Related]  

  • 13. HCFA makes concession on 'Stark I' exemptions.
    Jaklevic MC
    Mod Healthc; 1995 Oct; 25(44):48. PubMed ID: 10152138
    [No Abstract]   [Full Text] [Related]  

  • 14. Are cardiac-catheterization services Stark designated health services?
    Becker S; Kannensohn K
    Benders Health Care Law Mon; 1997 Aug; ():6-8. PubMed ID: 10173889
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase I of the Stark II final rule.
    Wachler AB; Avery PA
    Mich Health Hosp; 2001; 37(4):52-3. PubMed ID: 11467128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCFA implementation of Stark II law examines motive in payment review.
    Caesar N
    Manag Care; 1998 Aug; 7(8):52-3. PubMed ID: 10182585
    [No Abstract]   [Full Text] [Related]  

  • 17. Stark II: the quagmire thickens.
    Ivers D
    J Ark Med Soc; 1998 Jul; 95(2):75-8. PubMed ID: 9676062
    [No Abstract]   [Full Text] [Related]  

  • 18. HCFA needs to shine some light through Stark II's murkiness on 'gifts'.
    Caesar N
    Manag Care; 1998 Nov; 7(11):56-7. PubMed ID: 10187130
    [No Abstract]   [Full Text] [Related]  

  • 19. Remuneration arrangements important part of Stark II regulations.
    Caesar N
    Manag Care; 1998 Jul; 7(7):65-6. PubMed ID: 10181941
    [No Abstract]   [Full Text] [Related]  

  • 20. Can it be--Pete Stark, the doctor's pal?. Interview by Michael Pretzer.
    Stark P
    Med Econ; 1998 Dec; 75(24):45-6, 48-9. PubMed ID: 10338829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.